Your browser is no longer supported. Please, upgrade your browser.
Settings
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E311.21 EPS (ttm)0.73 Insider Own0.30% Shs Outstand267.34M Perf Week0.61%
Market Cap60.49B Forward P/E17.94 EPS next Y12.61 Insider Trans-27.94% Shs Float266.53M Perf Month-2.01%
Income171.00M PEG22.07 EPS next Q2.86 Inst Own87.10% Short Float1.90% Perf Quarter3.63%
Sales13.50B P/S4.48 EPS this Y2.70% Inst Trans1.72% Short Ratio4.31 Perf Half Y2.14%
Book/sh79.11 P/B2.86 EPS next Y14.75% ROA-0.20% Target Price252.06 Perf Year21.24%
Cash/sh4.74 P/C47.74 EPS next 5Y14.10% ROE-0.60% 52W Range185.03 - 248.39 Perf YTD5.69%
Dividend3.00 P/FCF69.76 EPS past 5Y-2.80% ROI4.80% 52W High-8.91% Beta1.13
Dividend %1.33% Quick Ratio1.10 Sales past 5Y9.40% Gross Margin46.00% 52W Low22.28% ATR3.67
Employees41900 Current Ratio1.70 Sales Q/Q42.20% Oper. Margin4.40% RSI (14)51.30 Volatility1.49% 1.65%
OptionableYes Debt/Eq1.08 EPS Q/Q-111.80% Profit Margin-0.70% Rel Volume1.20 Prev Close225.54
ShortableYes LT Debt/Eq1.07 EarningsMay 03 BMO Payout- Avg Volume1.18M Price226.25
Recom1.90 SMA20-0.44% SMA500.96% SMA2004.49% Volume1,413,601 Change0.31%
Apr-10-18Upgrade Citigroup Neutral → Buy
Jan-19-18Resumed BofA/Merrill Buy $260
Jan-05-18Upgrade Citigroup Sell → Neutral
Jan-05-18Initiated KeyBanc Capital Mkts Overweight
Jan-03-18Initiated Evercore ISI Outperform
Dec-29-17Reiterated Deutsche Bank Buy $239 → $260
Nov-03-17Reiterated RBC Capital Mkts Sector Perform $210 → $230
Sep-22-17Initiated Wells Fargo Outperform $225
Jun-30-17Upgrade Raymond James Outperform → Strong Buy
Jan-05-17Downgrade Raymond James Strong Buy → Outperform
Jan-03-17Downgrade JP Morgan Overweight → Neutral
Sep-23-16Downgrade Citigroup Neutral → Sell
May-09-16Reiterated RBC Capital Mkts Sector Perform $153 → $169
Feb-11-16Upgrade Deutsche Bank Hold → Buy $155 → $163
Feb-04-16Reiterated RBC Capital Mkts Sector Perform $162 → $153
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-12-15Initiated Citigroup Neutral
Aug-19-15Reiterated Argus Buy $156 → $167
Aug-10-15Reiterated Deutsche Bank Hold $147 → $155
Aug-07-15Reiterated RBC Capital Mkts Sector Perform $150 → $162
May-21-18 09:31AM  What Is Becton Dickinson and Companys (NYSE:BDX) Share Price Doing? Simply Wall St.
May-17-18 02:39AM  What does Budimex SAs (WSE:BDX) Balance Sheet Tell Us About Its Future? Simply Wall St.
May-11-18 04:39PM  U.S. investigates bloodstream infections for link to heparin syringes Reuters
May-08-18 07:50AM  Free Post Earnings Research Report: Illuminas Quarterly Revenue Surged 31%; Adjusted EPS Soared 127% ACCESSWIRE
May-07-18 07:55PM  Becton, Dickinson Starts the Bard Integration Off on a Solid Note Motley Fool
May-04-18 11:46AM  Edited Transcript of BDX earnings conference call or presentation 3-May-18 12:00pm GMT Thomson Reuters StreetEvents
May-03-18 11:50AM  Becton Dickinson and Company (BDX) Q2 2018 Earnings Conference Call Transcript Motley Fool
10:21AM  Becton, Dickinson (BDX) Beats on Q2 Earnings, Lifts '18 View Zacks
08:00AM  Stocks making the biggest moves premarket: CI, BDX, REGN, LOGI, KHC, APRN & more CNBC
07:37AM  Becton, Dickinson (BDX) Beats on Q2 Earnings & Revenues Zacks
06:10AM  Becton Dickinson: Fiscal 2Q Earnings Snapshot Associated Press
06:00AM  BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance PR Newswire
May-02-18 10:31AM  Medical Products Stock Earnings on May 3: BDX, CAH & More Zacks
08:30AM  Should You Sell Becton, Dickinson (BDX) Before Earnings? Zacks
Apr-27-18 06:59AM  BD Names Three Executives to Segment Leadership Roles PR Newswire
Apr-26-18 06:59AM  BD Launches BD FACSymphony S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types PR Newswire
Apr-23-18 04:30PM  BD Board Declares Dividends PR Newswire
Apr-19-18 06:59AM  BD Unveils Suite of Diagnostic Informatics and Automation Innovations PR Newswire
Apr-10-18 02:14PM  Citi Projects 16% Upside For Becton Dickinson In Upgrade Benzinga
Apr-03-18 04:30PM  BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call PR Newswire
Mar-22-18 01:27PM  BD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection Tubes PR Newswire
Mar-19-18 04:57PM  [$$] Apax Buying Remaining Stake in Vyaire Medical for $435 Million The Wall Street Journal
11:38AM  BD to Divest Remaining Investment in Vyaire Medical to Funds Managed by Apax Partners PR Newswire
11:04AM  Vyaire Medical, Inc -- Moody's assigns B3 CFR to Vyaire Medical; Outlook stable Moody's
Mar-15-18 09:45AM  Diabetes Devices Market on a Tear: 3 Stocks for Solid Returns Zacks
Mar-08-18 04:30PM  BD to Present at the Barclays Global Healthcare Conference PR Newswire
10:07AM  Becton, Dickinson (BDX) Down 1.3% Since Last Earnings Report Zacks
Mar-06-18 11:37AM  Becton Dickinson Has A Strong, Diverse Pipeline, But Is Fairly Valued, Says BMO Benzinga
09:47AM  Chimerix Q4 Loss Narrower Than Expected, Revenues Exceed Zacks
08:00AM  12 Beaten Down Health Care Stocks Set to Rebound Investopedia
Mar-05-18 10:25AM  Bio-Rad (BIO) Q4 Earnings Improve Y/Y, Revenues Top Mark Zacks
08:11AM  OPKO Health (OPK) Q4 Earnings Decline Y/Y, Margins Down Zacks
06:59AM  BD to Demonstrate Enhanced Integration Offerings that Target Key Gaps Across the Medication Management Process at HIMSS18 PR Newswire
Mar-02-18 10:52AM  DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q4 Zacks
Mar-01-18 08:00PM  BD Announces Results of Offer to Repurchase its 3.000% Notes Due 2026 PR Newswire
10:09AM  Zacks Industry Outlook Highlights: Abbott, Becton and Dickinson, Stryker, Varian Medical and Boston Scientific Zacks
Feb-28-18 04:30PM  BD to Present at the Raymond James 39th Annual Institutional Investors Conference PR Newswire
07:29AM  Integra LifeSciences (IART) Beats on Q4 Earnings & Revenues Zacks
Feb-27-18 04:53PM  Medtronic (MDT) Expands in the U.S. with 2.0mm DES Launch Zacks
10:05AM  NuVasive (NUVA) Meets Q4 Earnings Estimates, Issues '18 View Zacks
09:48AM  PetMed (PET) Focuses on Advertising to Boost New Order Sales Zacks
Feb-22-18 09:15AM  5 Reasons Why You Should Add Becton, Dickinson (BDX) Now Zacks
Feb-21-18 05:24PM  BD (BDX) Launches PAXgene in Europe for Advanced DNA Testing Zacks
Feb-20-18 06:59AM  BD Launches Circulating Cell-Free DNA Blood Collection Tube for Cancer and Non-Invasive Prenatal Testing Applications PR Newswire
Feb-16-18 09:54AM  Edwards Lifesciences' CE Mark for CENTERA Boosts THVT Arm Zacks
Feb-15-18 08:01AM  Chemed (CHE) Beats on Q4 Earnings & Revenues, Issues View Zacks
07:20AM  Blog Exposure - Becton, Dickinsons New HPV Test BD Onclarity(TM) HPV Assay Gets FDA Approval ACCESSWIRE
06:55AM  BD Completes Asset Divestitures to Merit Medical PR Newswire
Feb-14-18 08:08AM  GNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue Estimates Zacks
Feb-13-18 04:15PM  Amazon Could Enter Hospital Supply Chain Why Medtech Shouldn't Worry Investor's Business Daily
07:23AM  Luminex (LMNX) Beats on Q4 Earnings & Revenues, Issues View Zacks
06:59AM  FDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical Cancer PR Newswire
06:53AM  Becton, Dickinson Gains on Strong Q1 Results & Acquisitions Zacks
Feb-12-18 10:19AM  Amedisys (AMED) Strong on Home Health, Margin Decline a Woe Zacks
08:58AM  Haemonetics (HAE) Banks on Plasma Franchise, Competition Rife Zacks
Feb-09-18 09:57AM  Bruker (BRKR) Beats on Q4 Earnings & Revenues, Issues View Zacks
09:51AM  Hologic (HOLX) Q1 Earnings & Revenues Top, Margins Down Zacks
09:30AM  Surmodics (SRDX) Beats on Earnings in Q1, Guidance Solid Zacks
Feb-08-18 04:30PM  BD to Present at Leerink Partners 7th Annual Global Healthcare Conference PR Newswire
02:43PM  CVS Health (CVS) Q4 Earnings Beat Estimates, '18 View Upbeat Zacks
11:39AM  Cardinal Health (CAH) Beats on Q2 Earnings, Raises '18 View Zacks
09:18AM  Cardiovascular Systems (CSII) Q2 Earnings Top, Revenues Lag Zacks
09:12AM  STERIS (STE) Q3 Earnings Beat & Revenues Miss, Margins Up Zacks
Feb-07-18 08:01PM  Becton Dickinson (BDX) Q1 2018 Earnings Conference Call Transcript Motley Fool
04:35PM  Becton, Dickinson Ready to Sing a New Song Motley Fool
10:02AM  Myriad Genetics (MYGN) Beats on Earnings & Revenues in Q2 Zacks
Feb-06-18 09:49AM  Becton, Dickinson (BDX) Beats on Q1 Earnings, Guidance Solid Zacks
08:19AM  A Regular Winning Trade Becomes Roadkill in Market Meltdown TheStreet.com
07:35AM  Becton (BDX) Beats on Q1 Earnings and Revenues Estimates Zacks
06:23AM  Becton Dickinson reports 1Q loss Associated Press
06:03AM  BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard PR Newswire
Feb-05-18 09:50AM  Medical Product Stocks' Earnings on Feb 6: BDX, LH & More Zacks -5.18%
08:10AM  Research Report Identifies Franklin Electric Co., Univest Corporation of Pennsylvania, Otter Tail, First Horizon National, Pepsico, and Becton, Dickinson with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-02-18 08:48PM  Comparable Historical Revenue Schedules Inclusive of C. R. Bard Posted to BD Website PR Newswire
08:52AM  Should You Buy Becton, Dickinson (BDX) Ahead of Earnings? Zacks
Feb-01-18 06:59AM  BD Launches New Los Angeles County Program to Equip Patients with Essential Resources for Safe Sharps Disposal PR Newswire
Jan-29-18 09:51AM  Quality Systems (QSII) Q3 Earnings in Line, Revenues Beat Zacks
Jan-26-18 12:36PM  Four stock picks from a money manager focused on dividend growth for over two decades MarketWatch
07:36AM  Will ZBH Beat Wall Street Earnings Estimates in 4Q17? Market Realist
07:34AM  Could Thermo Fisher Scientific See Earnings Growth in 4Q17? Market Realist
Jan-25-18 11:37AM  Analyst Ratings for Thermo Fisher Scientific before 4Q17 Results Market Realist
07:54AM  What's in Store for Becton, Dickinson (BDX) in Q1 Earnings? Zacks
Jan-23-18 12:39PM  What Analysts Recommend for Intuitive Surgical ahead of 4Q17 Market Realist
Jan-22-18 04:30PM  BD Board Declares Dividend PR Newswire
09:02AM  What JNJs Stock Valuation Tells Us Market Realist
07:36AM  What to Expect from Abbott Laboratories 4Q17 Results Market Realist
Jan-19-18 05:50PM  Varian Medical Systems: Earnings Expected to Rise 26.8% in 1Q18 Market Realist
04:35PM  Will Abbotts 4Q17 Sales Results Exceed Analysts Expectations? Market Realist
03:27PM  Top Analyst Reports for UnitedHealth, Amgen & United Technologies Zacks
03:01PM  Wall Street Is Increasingly Bullish on ABT ahead of 4Q17 Results Market Realist
09:50AM  What to Expect from JNJs Medical Device Segment in 4Q17? Market Realist
07:14AM  Becton, Dickinson Completes Enrollment in Lutonix DCB Trial Zacks
Jan-18-18 08:55AM  BD Announces Completion of Enrollment in the Lutonix 014 Drug Coated Balloon Below-The-Knee Trial PR Newswire
07:23AM  Becton, Dickinson Hits a 52-Week High: What's Driving It? Zacks
Jan-17-18 04:30PM  BD Announces Webcast of Annual Meeting of Shareholders PR Newswire
10:42AM  10 Super Safe Growth Stocks to Buy for Long-Lasting Dividends InvestorPlace
09:20AM  BD's CE Mark and Check-Point's Screening Test to Fight CPO Zacks
Jan-16-18 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Jan-15-18 09:02AM  What Are Accelerate Diagnostics Key Strengths? Market Realist
07:33AM  Does Accelerate Diagnostics Financial Performance Bode Well? Market Realist
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy AlexandreExecutive Vice PresidentMay 21Option Exercise74.7229,9102,234,99438,199May 23 08:13 AM
Conroy AlexandreExecutive Vice PresidentMay 21Sale228.7420,1284,604,07926,436May 23 08:13 AM
Shabshab NabilExecutive Vice PresidentMay 11Option Exercise100.6018,4001,850,98421,546May 14 10:02 AM
Shabshab NabilExecutive Vice PresidentMay 11Sale226.1010,2092,308,2557,811May 14 10:02 AM
Melcher David FDirectorMay 07Buy225.07500112,5352,728May 09 12:44 PM
Polen Thomas E JrExecutive Vice PresidentMar 13Option Exercise108.892,775302,17015,387Mar 14 09:12 AM
Polen Thomas E JrExecutive Vice PresidentMar 13Sale227.001,877426,07912,178Mar 14 09:12 AM
Gallagher John EVP, Corp Finance and TreasurerFeb 28Sale226.3092,0372,099Mar 01 08:40 AM
Gallagher John EVP, Corp Finance and TreasurerFeb 27Option Exercise76.185,746437,7309,391Mar 01 08:40 AM
Gallagher John EVP, Corp Finance and TreasurerFeb 27Sale226.085,3461,208,6242,108Mar 01 08:40 AM
Borzi James WEVP & Chief Supply Chain OffcrFeb 26Option Exercise224.975,7381,290,8788,056Feb 27 03:00 PM
Borzi James WEVP & Chief Supply Chain OffcrFeb 26Sale224.984,048910,7262,253Feb 27 03:00 PM
RING TIMOTHY MDirectorFeb 23Sale218.2717638,416231Feb 27 02:34 PM
RING TIMOTHY MDirectorFeb 08Option Exercise102.53487,14849,949,423295,753Feb 12 02:56 PM
RING TIMOTHY MDirectorFeb 08Sale217.82269,66158,737,559170,688Feb 12 02:56 PM
COHEN GARY MExecutive Vice PresidentSep 11Option Exercise72.1224,0111,731,67395,781Sep 11 02:48 PM
COHEN GARY MExecutive Vice PresidentSep 11Sale203.7715,5123,160,88071,770Sep 11 02:48 PM
Sichak StephenExecutive Vice PresidentSep 08Option Exercise113.0427,0333,055,69219,047Sep 11 09:17 AM
Sichak StephenExecutive Vice PresidentSep 08Sale200.4611,7872,362,8227,953Sep 11 09:17 AM
Lim James CExecutive Vice PresidentSep 08Sale204.063,500714,21014,135Sep 11 09:10 AM
COHEN GARY MExecutive Vice PresidentAug 22Option Exercise72.1223,5001,694,82095,270Aug 23 05:11 PM
Tharby Linda MExecutive Vice PresidentAug 22Option Exercise72.127,333528,85618,670Aug 23 05:45 PM
Tharby Linda MExecutive Vice PresidentAug 22Sale200.484,695941,25411,337Aug 23 05:45 PM
COHEN GARY MExecutive Vice PresidentAug 22Sale200.4315,0443,015,26971,770Aug 23 05:11 PM
Shabshab NabilExecutive Vice PresidentAug 15Sale202.372,865579,7905,839Aug 16 10:12 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesAug 14Option Exercise76.1812,003914,38929,323Aug 14 04:52 PM
Shabshab NabilExecutive Vice PresidentAug 14Option Exercise140.2610,8431,520,88315,648Aug 16 10:12 AM
Shabshab NabilExecutive Vice PresidentAug 14Sale201.223,284660,8068,704Aug 16 10:12 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesAug 14Sale201.417,4631,503,12317,320Aug 14 04:52 PM
Strahlman Ellen RSenior Vice PresidentAug 10Option Exercise108.8920,6012,243,24326,638Aug 11 09:57 AM
Strahlman Ellen RSenior Vice PresidentAug 10Sale198.219,2831,839,9836,037Aug 11 09:57 AM
Polen Thomas E JrExecutive Vice PresidentAug 09Option Exercise98.9111,9711,184,06517,528Aug 10 10:08 AM
Polen Thomas E JrExecutive Vice PresidentAug 09Sale197.415,9711,178,7359,209Aug 10 10:08 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 25Option Exercise76.1848,7273,712,02370,821May 26 10:25 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 25Sale185.9828,7655,349,71522,094May 26 10:25 AM